For the Inventor, By the Inventor

Enter assignee name

Lexington, MA, United States of America

Quanterix Corporation

USPTO Granted Patents = 29

EPO Patents = 6

Trademarks = 7

Forward Citations = 538

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

David C Duffy (21 out of 36 patents)

David M Rissin (15 out of 23 patents)

David Fournier (15 out of 28 patents)

4. Cheuk Wai Kan (10 out of 15 patents)

5. David R Walt (10 out of 79 patents)

6. David Wilson (8 out of 8 patents)

7. Linan Song (7 out of 7 patents)

8. Jeffrey D Randall (6 out of 8 patents)

9. Dandan Shan (5 out of 5 patents)

10. Lei Chang (5 out of 5 patents)

11. John Henrik Zetterberg (4 out of 4 patents)

12. Kaj Blennow (4 out of 5 patents)

13. Todd Campbell (3 out of 5 patents)

14. Andrew Rivnak (3 out of 3 patents)

15. John Lawson (3 out of 6 patents)

29 patents: Sort by Forward Citations

1. 12571803 - Methods of producing bodily fluid samples containing an analytically quantified amount of phosphorylated tau protein (2026-03-10),

2. 12540950 - Methods of assaying phosphorylated tau protein in a sample (2026-02-03),

3. 12287343 - Quantification of neurofilament light chain in physiological samples (2025-04-29),

4. 12235267 - Ultra-sensitive detection of molecules or particles using beads or other capture objects (2025-02-25),

5. 12130294 - Quantification of biomarkers present in physiological samples (2024-10-29),

6. 12111324 - Quantification of biomarkers present in dried physiological samples (2024-10-08),

7. 12019072 - Methods and systems for extending dynamic range in assays for the detection of molecules or particles (2024-06-25),

8. 11977087 - Systems, devices, and methods for ultra-sensitive detection of molecules or particles (2024-05-07),

9. 11686730 - Quantitative antibody test (2023-06-27),

10. 11619631 - Ultra-sensitive detection of molecules or particles using beads or other capture objects (2023-04-04),

11. 11434264 - Immunoassays for differential detection of clostridium difficile (2022-09-06),

12. 11275092 - Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury (2022-03-15),

13. 11112415 - Systems, devices, and methods for ultra-sensitive detection of molecules or particles (2021-09-07),

14. 10989713 - Methods and systems for extending dynamic range in assays for the detection of molecules or particles (2021-04-27),

15. 10725032 - Ultra-sensitive detection of molecules or particles using beads or other capture objects (2020-07-28),

Quanterix Corporation is a leading provider of ultra-sensitive digital immunoassay platforms that empower researchers and clinical researchers to detect and measure protein biomarkers with unparalleled precision. Their innovative Simoa technology enables the detection and quantification of biomarkers at levels previously unattainable, opening new avenues for research, diagnostics, and development of therapeutics.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Quanterix Corporation

29 Patents

#31 in Lexington, MA

#694 in Massachusetts

#11,598 in US

#22,493 in the World

Lexington, MA, United States of America

Quanterix Corporation

Forward Citations = 538

30 inventors:

David C Duffy (21 out of 36 patents)

David M Rissin (15 out of 23 patents)

David Fournier (15 out of 28 patents)

4. Cheuk Wai Kan (10 out of 15 patents)

5. David R Walt (10 out of 79 patents)

Please report any incorrect information to [email protected]

Loading…